Should data and safety monitoring boards share confidential interim data?

Controlled Clinical Trials

Volumn 21, Issue 1, 2000, Pages 1-6

  Dixon, Dennis O ^a   Lagakos, Stephen W ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Clinical trial; Data sharing; DSMB procedures

Indexed keywords

CLINICAL TRIAL; CONFIDENTIALITY; DATA ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL INFORMATION; PATIENT MONITORING; REVIEW; SAFETY; STATISTICAL ANALYSIS;

EID: 0033959017     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(99)00042-2     Document Type: Article

References (4)

1. Ellenberg S., Geller N., Simon R., Yusuf S. Proceedings of "Practical Issues in Data Monitoring of Clinical Trials." Stat Med. 12:1993;415-616.
2. Geller N, Freedman L, Lee YJ, Dersimonian R, eds. Conference on Meta-Analysis in the Design and Monitoring of Clinical Trials. Stat Med 1996;15:1233-1323.
3. Fleming T.R., DeMets D.L. Monitoring of clinical trials. Issues and recommendations Control Clin Trials. 14:1993;183-197.
4. DeMets D.L., Fleming T.R., Whitley R.J.et al. The Data and Safety Monitoring Board and acquired immune deficiency syndrome (AIDS) clinical trials. Control Clin Trials. 16:1995;408-421.